Cargando…
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403570/ https://www.ncbi.nlm.nih.gov/pubmed/32759966 http://dx.doi.org/10.1038/s41422-020-0387-5 |
| _version_ | 1783566968218976256 |
|---|---|
| author | Tai, Wanbo Zhang, Xiujuan Drelich, Aleksandra Shi, Juan Hsu, Jason C. Luchsinger, Larry Hillyer, Christopher D. Tseng, Chien-Te K. Jiang, Shibo Du, Lanying |
| author_facet | Tai, Wanbo Zhang, Xiujuan Drelich, Aleksandra Shi, Juan Hsu, Jason C. Luchsinger, Larry Hillyer, Christopher D. Tseng, Chien-Te K. Jiang, Shibo Du, Lanying |
| author_sort | Tai, Wanbo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7403570 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74035702020-08-05 A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 Tai, Wanbo Zhang, Xiujuan Drelich, Aleksandra Shi, Juan Hsu, Jason C. Luchsinger, Larry Hillyer, Christopher D. Tseng, Chien-Te K. Jiang, Shibo Du, Lanying Cell Res Letter to the Editor Springer Singapore 2020-08-05 2020-10 /pmc/articles/PMC7403570/ /pubmed/32759966 http://dx.doi.org/10.1038/s41422-020-0387-5 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Tai, Wanbo Zhang, Xiujuan Drelich, Aleksandra Shi, Juan Hsu, Jason C. Luchsinger, Larry Hillyer, Christopher D. Tseng, Chien-Te K. Jiang, Shibo Du, Lanying A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 |
| title | A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 |
| title_full | A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 |
| title_fullStr | A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 |
| title_full_unstemmed | A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 |
| title_short | A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 |
| title_sort | novel receptor-binding domain (rbd)-based mrna vaccine against sars-cov-2 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403570/ https://www.ncbi.nlm.nih.gov/pubmed/32759966 http://dx.doi.org/10.1038/s41422-020-0387-5 |
| work_keys_str_mv | AT taiwanbo anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT zhangxiujuan anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT drelichaleksandra anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT shijuan anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT hsujasonc anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT luchsingerlarry anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT hillyerchristopherd anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT tsengchientek anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT jiangshibo anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT dulanying anovelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT taiwanbo novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT zhangxiujuan novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT drelichaleksandra novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT shijuan novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT hsujasonc novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT luchsingerlarry novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT hillyerchristopherd novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT tsengchientek novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT jiangshibo novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 AT dulanying novelreceptorbindingdomainrbdbasedmrnavaccineagainstsarscov2 |